Aurobindo Pharma Proposes Ramprasad Reddy To Head U.S. Subsidiary
This article was originally published in PharmAsia News
Executive Summary
Aurobindo Pharma's board proposed P.V. Ramprasad Reddy as executive chairman of its Aurobindo Pharma USA wholly owned subsidiary, subject to shareholder approval at a Sept. 27 meeting.